Cannabis Law Report
AUGUST 7, 2021
The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable, and accessible work environment. Ensure high quality, timely, and consistent submission of regulatory documents.
NORML
JANUARY 31, 2019
“These men and women put on the uniform to defend this nation’s freedoms and it is the height of hypocrisy for the federal government to deny them rights afforded to the millions of other Americans who reside in states where access to medical cannabis is legally recognized.”
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Veriheal
JUNE 30, 2023
For their analysis, researchers conducted qualitative interviews with 13 individuals who had participated in a psilocybin clinical trial. The 13 individuals were chosen because of their reported improvements in negative drinking behavior following the clinical trial.
Cannabis Law Report
NOVEMBER 19, 2021
It has been designated a Breakthrough Therapy by the FDA and the results of our pivotal Phase 3 clinical trial were published in Nature Medicine or profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable and accessible work environment. European Regulatory Lead Executive Summary.
Cannabis Law Report
JULY 28, 2021
MAPS PBC strives to continually improve upon the supportive, equitable and accessible work environment. Reporting to the Regulatory Affairs Manager, the RPS supports functions related to tracking regulatory information and document styling and publishing in eCTD format for regulatory submissions.
Cannabis Law Report
OCTOBER 2, 2021
The results of our successful pivotal Phase 3 clinical trial were recently published in Nature Medicine and profiled on the front page of The New York Times. MAPS PBC strives to establish a supportive, equitable, and accessible work environment. Ensure high quality, timely, and consistent submission of regulatory documents.
Cannabis Law Report
FEBRUARY 5, 2022
Responsible for creation and maintenance of all regulatory documentation, including but not limited to, product packaging, labelling, inserts, working in conjunction with the marketing team for design, and assuring regulatory compliance across all territories. Support new product development and further clinical activities.
Expert insights. Personalized for you.
105 
Let's personalize your content